|
1
|
Zhao FQ: Octamer-binding transcription
factors: Genomics and functions. Front Biosci. 18:1051–1071. 2013.
View Article : Google Scholar
|
|
2
|
Qian X and Zhao FQ: Regulatory roles of
Oct proteins in the mammary gland. Biochim Biophys Acta.
1859:812–819. 2016. View Article : Google Scholar
|
|
3
|
Schöler HR, Dressler GR, Balling R,
Rohdewohld H and Gruss P: Oct-4: A germline-specific transcription
factor mapping to the mouse t-complex. EMBO J. 9:2185–2195.
1990.
|
|
4
|
Niwa H, Miyazaki J and Smith AG:
Quantitative expression of Oct-3/4 defines differentiation,
dedifferentiation or self-renewal of ES cells. Nat Genet.
24:372–376. 2000. View
Article : Google Scholar
|
|
5
|
Babaie Y, Herwig R, Greber B, Brink TC,
Wruck W, Groth D, Lehrach H, Burdon T and Adjaye J: Analysis of
Oct4-dependent transcriptional networks regulating self-renewal and
pluripotency in human embryonic stem cells. Stem Cells. 25:500–510.
2007. View Article : Google Scholar
|
|
6
|
Pesce M and Schöler HR: Oct-4: Gatekeeper
in the beginnings of mammalian development. Stem Cells. 19:271–278.
2001. View Article : Google Scholar
|
|
7
|
Pesce M and Schöler HR: Oct-4: Control of
totipotency and germline determination. Mol Reprod Dev. 55:452–457.
2000. View Article : Google Scholar
|
|
8
|
Tai MH, Chang CC, Kiupel M, Webster JD,
Olson LK and Trosko JE: Oct4 expression in adult human stem cells:
Evidence in support of the stem cell theory of carcinogenesis.
Carcinogenesis. 26:495–502. 2005. View Article : Google Scholar
|
|
9
|
Gidekel S, Pizov G, Bergman Y and Pikarsky
E: Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer
Cell. 4:361–370. 2003. View Article : Google Scholar
|
|
10
|
de Jong J and Looijenga LH: Stem cell
marker OCT3/4 in tumor biology and germ cell tumor diagnostics:
History and future. Crit Rev Oncog. 12:171–203. 2006. View Article : Google Scholar
|
|
11
|
Monk M and Holding C: Human embryonic
genes re-expressed in cancer cells. Oncogene. 20:8085–8091. 2001.
View Article : Google Scholar
|
|
12
|
Jin T, Branch DR, Zhang X, Qi S, Youngson
B and Goss PE: Examination of POU homeobox gene expression in human
breast cancer cells. Int J Cancer. 81:104–112. 1999. View Article : Google Scholar
|
|
13
|
Chen Z, Xu WR, Qian H, Zhu W, Bu XF, Wang
S, Yan YM, Mao F, Gu HB, Cao HL, et al: Oct4, a novel marker for
human gastric cancer. J Surg Oncol. 99:414–419. 2009. View Article : Google Scholar
|
|
14
|
Iki K and Pour PM: Expression of Oct4, a
stem cell marker, in the hamster pancreatic cancer model.
Pancreatology. 6:406–413. 2006. View Article : Google Scholar
|
|
15
|
Saigusa S, Tanaka K, Toiyama Y, Yokoe T,
Okugawa Y, Ioue Y, Miki C and Kusunoki M: Correlation of CD133,
OCT4, and SOX2 in rectal cancer and their association with distant
recurrence after chemoradiotherapy. Ann Surg Oncol. 16:3488–3498.
2009. View Article : Google Scholar
|
|
16
|
Li B, Yao Z, Wan Y and Lin D:
Overexpression of OCT4 is associated with gefitinib resistance in
non-small cell lung cancer. Oncotarget. 7:77342–77347. 2016.
|
|
17
|
Zhou J, Dong D, Cheng R, Wang Y, Jiang S,
Zhu Y, Fan L, Mao X, Gui Y, Li Z, et al: Aberrant expression of
KPNA2 is associated with a poor prognosis and contributes to OCT4
nuclear transportation in bladder cancer. Oncotarget.
7:72767–72776. 2016.
|
|
18
|
Asadi MH, Khalifeh K and Mowla SJ: OCT4
spliced variants are highly expressed in brain cancer tissues and
inhibition of OCT4B1 causes G2/M arrest in brain cancer cells. J
Neurooncol. 130:455–463. 2016. View Article : Google Scholar
|
|
19
|
Hochedlinger K, Yamada Y, Beard C and
Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell
differentiation and causes dysplasia in epithelial tissues. Cell.
121:465–477. 2005. View Article : Google Scholar
|
|
20
|
Cai S, Geng S, Jin F, Liu J, Qu C and Chen
B: POU5F1/Oct-4 expression in breast cancer tissue is significantly
associated with non-sentinel lymph node metastasis. BMC Cancer.
16:1752016. View Article : Google Scholar
|
|
21
|
Wang D, Lu P, Zhang H, Luo M, Zhang X, Wei
X, Gao J, Zhao Z and Liu C: Oct-4 and Nanog promote the
epithelial-mesenchymal transition of breast cancer stem cells and
are associated with poor prognosis in breast cancer patients.
Oncotarget. 5:10803–10815. 2014.
|
|
22
|
Wang P, Branch DR, Bali M, Schultz GA,
Goss PE and Jin T: The POU homeodomain protein OCT3 as a potential
transcriptional activator for fibroblast growth factor-4 (FGF-4) in
human breast cancer cells. Biochem J. 375:199–205. 2003. View Article : Google Scholar
|
|
23
|
McLeskey SW, Kurebayashi J, Honig SF,
Zwiebel J, Lippman ME, Dickson RB and Kern FG: Fibroblast growth
factor 4 transfection of MCF-7 cells produces cell lines that are
tumorigenic and metastatic in ovariectomized or tamoxifen-treated
athymic nude mice. Cancer Res. 53:2168–2177. 1993.
|
|
24
|
Kim RJ and Nam JS: OCT4 expression
enhances features of cancer stem cells in a mouse model of breast
cancer. Lab Anim Res. 27:147–152. 2011. View Article : Google Scholar
|
|
25
|
Pain D, Chirn GW, Strassel C and Kemp DM:
Multiple retropseudogenes from pluripotent cell-specific gene
expression indicates a potential signature for novel gene
identification. J Biol Chem. 280:6265–6268. 2005. View Article : Google Scholar
|
|
26
|
Suo G, Han J, Wang X, Zhang J, Zhao Y,
Zhao Y and Dai J: Oct4 pseudogenes are transcribed in cancers.
Biochem Biophys Res Commun. 337:1047–1051. 2005. View Article : Google Scholar
|
|
27
|
Takeda J, Seino S and Bell GI: Human Oct3
gene family: cDNA sequences, alternative splicing, gene
organization, chromosomal location, and expression at low levels in
adult tissues. Nucleic Acids Res. 20:4613–4620. 1992. View Article : Google Scholar
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Gwak JM, Kim M, Kim HJ, Jang MH and Park
SY: Expression of embryonal stem cell transcription factors in
breast cancer: Oct4 as an indicator for poor clinical outcome and
tamoxifen resistance. Oncotarget. 8:36305–36318. 2017. View Article : Google Scholar
|
|
30
|
Kaufhold S, Garbán H and Bonavida B: Yin
Yang 1 is associated with cancer stem cell transcription factors
(SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res.
35:842016. View Article : Google Scholar
|
|
31
|
Liu T, Sun B, Zhao X, Li Y, Gu Q, Dong X
and Liu F: OCT4 expression and vasculogenic mimicry formation
positively correlate with poor prognosis in human breast cancer.
Int J Mol Sci. 15:19634–19649. 2014. View Article : Google Scholar
|
|
32
|
Wang X, Zhao Y, Xiao Z, Chen B, Wei Z,
Wang B, Zhang J, Han J, Gao Y, Li L, et al: Alternative translation
of OCT4 by an internal ribosome entry site and its novel function
in stress response. Stem Cells. 27:1265–1275. 2009. View Article : Google Scholar
|
|
33
|
Zhao S, Yuan Q, Hao H, Guo Y, Liu S, Zhang
Y, Wang J, Liu H, Wang F, Liu K, et al: Expression of OCT4
pseudogenes in human tumours: Lessons from glioma and breast
carcinoma. J Pathol. 223:672–682. 2011. View Article : Google Scholar
|
|
34
|
Cotsarelis G, Sun TT and Lavker RM:
Label-retaining cells reside in the bulge area of pilosebaceous
unit: Implications for follicular stem cells, hair cycle, and skin
carcinogenesis. Cell. 61:1329–1337. 1990. View Article : Google Scholar
|
|
35
|
Aguilar-Gallardo C and Simón C: Cells,
stem cells, and cancer stem cells. Semin Reprod Med. 31:5–13. 2013.
View Article : Google Scholar
|
|
36
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar
|
|
37
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007. View Article : Google Scholar
|
